Cargando…

Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study

AIMS/HYPOTHESIS: Our aim was to study the association between duration of breastfeeding and circulating immunological markers during the first 3 years of life in children with HLA-conferred susceptibility to type 1 diabetes. METHODS: We performed a longitudinal analysis of 38 circulating immunologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Miettinen, Maija E., Honkanen, Jarno, Niinistö, Sari, Vaarala, Outi, Virtanen, Suvi M., Knip, Mikael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741720/
https://www.ncbi.nlm.nih.gov/pubmed/34837504
http://dx.doi.org/10.1007/s00125-021-05612-2
_version_ 1784629554229280768
author Miettinen, Maija E.
Honkanen, Jarno
Niinistö, Sari
Vaarala, Outi
Virtanen, Suvi M.
Knip, Mikael
author_facet Miettinen, Maija E.
Honkanen, Jarno
Niinistö, Sari
Vaarala, Outi
Virtanen, Suvi M.
Knip, Mikael
author_sort Miettinen, Maija E.
collection PubMed
description AIMS/HYPOTHESIS: Our aim was to study the association between duration of breastfeeding and circulating immunological markers during the first 3 years of life in children with HLA-conferred susceptibility to type 1 diabetes. METHODS: We performed a longitudinal analysis of 38 circulating immunological markers (cytokines, chemokines and growth factors) in serum samples from Finnish (56 individuals, 147 samples), Estonian (56 individuals 148 samples) and Russian Karelian children (62 individuals, 149 samples) at 3, 6, 12, 18, 24 and 36 months of age. We also analysed gut inflammation markers (calprotectin and human β defensin-2) at 3 (n = 96) and 6 months (n = 153) of age. Comparisons of immunological marker medians were performed between children who were breastfed for 6 months or longer vs children who were breastfed for less than 6 months. RESULTS: Breastfeeding for 6 months or longer vs less than 6 months was associated with lower median of serum immunological markers at 6 months (granulocyte-macrophage colony-stimulating factor [GMCSF], macrophage inflammatory protein [MIP-3α]), 12 months (IFN-α2, vascular endothelial growth factor, GMCSF, IFN-γ, IL-21), 18 months (FGF-2, IFN-α2) and 24 months of age (CCL11 [eotaxin], monocyte chemoattractant protein-1, TGFα, soluble CD40 ligand, IL-13, IL-21, IL-5, MIP-1α) (all p < 0.01) but not at 36 months of age. Breastfeeding was not associated with gut inflammation markers at 3 and 6 months of age. CONCLUSIONS/INTERPRETATION: Children who were breastfed for 6 months or longer had lower medians for 14 immunological markers at one or more age points during the first 2 years of life compared with children who were breastfed for less than 6 months. The clinical meaning of the findings is not clear. However, the present study contributes to the understanding of immunological differences in children that have been breastfed longer, and thus provides a mechanistic suggestion for the previously observed associations between breastfeeding and risk of type 1 diabetes. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-8741720
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-87417202022-01-20 Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study Miettinen, Maija E. Honkanen, Jarno Niinistö, Sari Vaarala, Outi Virtanen, Suvi M. Knip, Mikael Diabetologia Short Communication AIMS/HYPOTHESIS: Our aim was to study the association between duration of breastfeeding and circulating immunological markers during the first 3 years of life in children with HLA-conferred susceptibility to type 1 diabetes. METHODS: We performed a longitudinal analysis of 38 circulating immunological markers (cytokines, chemokines and growth factors) in serum samples from Finnish (56 individuals, 147 samples), Estonian (56 individuals 148 samples) and Russian Karelian children (62 individuals, 149 samples) at 3, 6, 12, 18, 24 and 36 months of age. We also analysed gut inflammation markers (calprotectin and human β defensin-2) at 3 (n = 96) and 6 months (n = 153) of age. Comparisons of immunological marker medians were performed between children who were breastfed for 6 months or longer vs children who were breastfed for less than 6 months. RESULTS: Breastfeeding for 6 months or longer vs less than 6 months was associated with lower median of serum immunological markers at 6 months (granulocyte-macrophage colony-stimulating factor [GMCSF], macrophage inflammatory protein [MIP-3α]), 12 months (IFN-α2, vascular endothelial growth factor, GMCSF, IFN-γ, IL-21), 18 months (FGF-2, IFN-α2) and 24 months of age (CCL11 [eotaxin], monocyte chemoattractant protein-1, TGFα, soluble CD40 ligand, IL-13, IL-21, IL-5, MIP-1α) (all p < 0.01) but not at 36 months of age. Breastfeeding was not associated with gut inflammation markers at 3 and 6 months of age. CONCLUSIONS/INTERPRETATION: Children who were breastfed for 6 months or longer had lower medians for 14 immunological markers at one or more age points during the first 2 years of life compared with children who were breastfed for less than 6 months. The clinical meaning of the findings is not clear. However, the present study contributes to the understanding of immunological differences in children that have been breastfed longer, and thus provides a mechanistic suggestion for the previously observed associations between breastfeeding and risk of type 1 diabetes. GRAPHICAL ABSTRACT: [Image: see text] Springer Berlin Heidelberg 2021-11-27 2022 /pmc/articles/PMC8741720/ /pubmed/34837504 http://dx.doi.org/10.1007/s00125-021-05612-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Short Communication
Miettinen, Maija E.
Honkanen, Jarno
Niinistö, Sari
Vaarala, Outi
Virtanen, Suvi M.
Knip, Mikael
Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study
title Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study
title_full Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study
title_fullStr Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study
title_full_unstemmed Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study
title_short Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study
title_sort breastfeeding and circulating immunological markers during the first 3 years of life: the diabimmune study
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741720/
https://www.ncbi.nlm.nih.gov/pubmed/34837504
http://dx.doi.org/10.1007/s00125-021-05612-2
work_keys_str_mv AT miettinenmaijae breastfeedingandcirculatingimmunologicalmarkersduringthefirst3yearsoflifethediabimmunestudy
AT honkanenjarno breastfeedingandcirculatingimmunologicalmarkersduringthefirst3yearsoflifethediabimmunestudy
AT niinistosari breastfeedingandcirculatingimmunologicalmarkersduringthefirst3yearsoflifethediabimmunestudy
AT vaaralaouti breastfeedingandcirculatingimmunologicalmarkersduringthefirst3yearsoflifethediabimmunestudy
AT virtanensuvim breastfeedingandcirculatingimmunologicalmarkersduringthefirst3yearsoflifethediabimmunestudy
AT knipmikael breastfeedingandcirculatingimmunologicalmarkersduringthefirst3yearsoflifethediabimmunestudy
AT breastfeedingandcirculatingimmunologicalmarkersduringthefirst3yearsoflifethediabimmunestudy